| Dr Douglas Scott Files, MD | |
|
2325 Fifth Street, Usafsam/feee, Building 840, Wpafb, OH 45433 | |
| (937) 938-3102 | |
| (937) 904-6330 |
| Full Name | Dr Douglas Scott Files |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Aerospace Medicine |
| Location | 2325 Fifth Street, Wpafb, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548231426 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083A0100X | Preventive Medicine - Aerospace Medicine | ME72981 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas Scott Files, MD 2325 Fifth Street, Usafsam/feee, Building 840, Wpafb, OH 45433 Ph: (937) 938-3102 | Dr Douglas Scott Files, MD 2325 Fifth Street, Usafsam/feee, Building 840, Wpafb, OH 45433 Ph: (937) 938-3102 |
News Archive
As a founding member, the Institute for Quality and Efficiency in Health Care (IQWiG) has been involved in EUnetHTA, a European network for Health Technology Assessment (HTA), since 2006.
Androgen-deprivation therapy (ADT), commonly used to treat prostate cancer, can worsen heart risk factors and may increase the risk of heart attack and/or cardiac death, although the relationship between ADT and heart attack or cardiac death has not been definitively established, according to a science advisory published in Circulation: Journal of the American Heart Association and CA: A Cancer Journal for Clinicians.
Based on its recent analysis of the endoscopic imaging market, Frost & Sullivan recognizes Sanovas Inc. with the 2014 Global Frost & Sullivan Award for New Product Innovation Leadership. In a market where spiralling healthcare costs impact the entire spectrum of stakeholders, Sanovas's ground-breaking endoscopic platform, MicroCam, provides the functionality of a high-end, flexible endoscope without the accompanying cost and maintenance burden.
Treatment with the vascular endothelial growth factor receptor inhibitor axitinib does not adversely affect renal function in patients with metastatic renal cell carcinoma even in the presence of proteinuria, a Japanese study indicates.
A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease.
› Verified 5 days ago
Dr. Paul Puchta, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-1771 Fax: 937-522-2128 | |
Dr. Joseph Connolly Iii, D.O. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-8718 Fax: 937-656-1347 |